Literature DB >> 4110794

Cyclophosphamide-induced tolerance to equine globulin and to equine-anti-mouse-thymocyte globulin in adult mice. I. Studies on antigen and drug requirements.

G D Stockman, J J Trentin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4110794

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  6 in total

1.  The antigenic and immunosuppressive properties of normal and antilymphocytic equine IgG subfractions.

Authors:  R A Allardyce; N F Anderson; J P Vaerman; K James
Journal:  Clin Exp Immunol       Date:  1973-02       Impact factor: 4.330

2.  The effect of cyclophosphamide on an ocular immune response. I. Primary response.

Authors:  J M Hall; S Ohno; J F Pribnow
Journal:  Clin Exp Immunol       Date:  1977-11       Impact factor: 4.330

3.  Direct evidence for clonal destruction of allo-reactive T cells in the mice treated with cyclophosphamide after allo-priming.

Authors:  T Maeda; M Eto; Y Nishimura; K Nomoto; Y Y Kong; K Nomoto
Journal:  Immunology       Date:  1993-01       Impact factor: 7.397

4.  Respiratory diseases in cyclophosphamide-treated mice. II. Decreased virulence of PR8 influenza virus.

Authors:  S H Singer; P Noguchi; R L Kirschstein
Journal:  Infect Immun       Date:  1972-06       Impact factor: 3.441

5.  Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barriers by a tolerance-inducing method using cyclophosphamide.

Authors:  H Mayumi; R A Good
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

6.  Hapten-specific T cell responses to 4-hydroxy-3-nitrophenyl acetyl. VIII. Suppressor cell pathways in cutaneous sensitivity responses.

Authors:  M E Sunday; B Benacerraf; M E Dorf
Journal:  J Exp Med       Date:  1981-04-01       Impact factor: 14.307
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.